Spatial OMICS Market Size by Application, Technology, Workflow, Sample Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2034
Overview
Spatial OMICS Market size was valued at US$ 436.48 Mn. in 2025 and expected to reach US$ 737.42 Mn. by 2034 at a CAGR of 6% during the forecast period.
Spatial OMICS Market Overview:
Spatial OMICS is related to the study of summarizing various analyses of proteomics, lipidomics, genomics, epigenomics, transcriptomics, and metabolomics. Spatial OMICS also combines molecular analysis with special information on the cell localization within the tissue. Spatialomics allows the researchers to identify the gene activity in the tissue sample and to identify the area of the activity taking place in the sample. Moreover, it also helps to understand the biological process of the diseases.
Spatial OMICS Market Size, Growth & Analysis
To know about the Research Methodology :- Request Free Sample Report
Spatial OMICS Market Dynamics:
The rising application of special OMICS for biomarker identification is a key factor boosting the growth of the market. To evaluate the toxicity and efficacy of the drug spatial OMICS play an important role and have simplified drug discovery and development. Biomarker identification together with the clinical application is greatly used in novel drug development. Biomarkers identify the Pathway of the diseases and the progression and help to understand the cause. Chronic diseases like Cancer, Cardiovascular Diseases (CVD), and Neurological Diseases greatly need the application of biomarkers.
In Addition, Biomarkers are fueling the demand in the transcriptomics technologies market. As the applications of transcriptomics in biomarker discovery are creating huge opportunities. Likewise, biomarkers are used to identify the infected region and to offer a target drug delivery system for potential diagnosis.
Moreover, the rising occurrence of cancer is likely to boost the market in the forecast period. As per GLOBOCAN, in 2019 around 18,959,989 new cancer cases were registered and this number is growing at a rapid pace and is estimated to reach 30.4 million by 2050. The rising prevalence of cancer is pushing researchers and scientists to improve the technologies for cancer treatment to decrease the pace and is simultaneously creating market players like 10x Genomics and Dovetail Genomics to invest in the market. Further, Cancer Immunology is a key driver of the Spatial OMICS market as it is important to study the tumor immunogenicity of the complex tumor microenvironment. To identify the immunogenicity spatial multi-omics are utilized as they are three-dimensional.
Further, lack of skilled professionals in the area of OMICS research is challenge to the market growth as spatial genomics and transcriptomics is a new area in discovery.
Spatial OMICS Market Segment Analysis:
Spatial Transcriptomics Technology Segment is dominating the Spatial OMICS Market:
Spatial Transcriptomics technology accounted for the largest market share of xx%in the year 2025 and is likely to sustain in the market at a growing pace throughout the forecast period. The growth is attributed to the availability of the products based on mRNA that is messenger-RNA analysis for the positioning information and rising demand for increasing adoptions of in-situ sequencing techniques. Moreover, the segment was valued at USD 121.3 Million in 2025 and is estimated to reach USD 551.06million by 2029 with a CAGR of 18.2% in the forecast period. Further, 10X Genomics is a leading company in the global market and is boosting the trend of spatial transcriptomics with the launch of the Visium Special Gene Expression platform. For In-situ analysis, the company acquired Cartana AB and READCoor in the year 2020.
The instruments segment is considered to supplement the growth of the Spatial OMICS Market:
The instrument segment is dominating with a revenue share of 49.5% in the year 2025. The instruments segment is further segmented by mode and type. In mode segment automated, semi-automated, and manual machinery. As advanced machinery is being developed with the latest technologies like high resolution, high speed, and this technology are used for studying complex biological samples. And this is further utilized in novel drug development, biomarkers, diagnostics, and product discoveries.
The academic and translational research institutes segment is gaining more attention in the special OMICS Market
The academic and translational research institutes are dominating the application segment with a revenue share of 91.3% in 2025. As the translational studies in the genomic sector help the researchers to analyze the behavior of human tissue and cells from different human beings in different climates and environments. Also, increasing the adoption of spatial OMICS to identify the tissue response to a foreign particle or external agent in translational research is further boosting the market growth in favorable conditions. Moreover, single-cell transcriptomics is used in neuroscientists to the cells forming the brain structure. Further, this process helps to identify the three-dimensional architecture of nervous tissues and assess the working of brains and their function.
Formalin Fixation And Paraffin-Embedding (FFPE): New Trend of Sample Type in the Global Spatial OMICS market:
Formalin Fixation and Paraffin-embedding (FFPE) segment held largest market share of 51.37% in 2025. FFPE is a standard sample used for the prevention of human tissue for clinical studies and diagnosis. And being the standard sample FFPE is used widely as this technique is finest for the research of tissue morphology and clinical diagnosis like histopathology. Moreover, FFPE samples are found on a large scale in clinical banks. And this abundance is motivating the market growth favorably. FFPE is also used in the preparation and preservation of the biopsy specimens and this is the key factor to fuel the market. As 1.67 million breast biopsies are performed each year globally as the radiologists spot something suspicious on mammography.
Spatial OMICS Market Regional Insights:
North America dominates the Spatial OMICS market owing to increasing development strategies made by various industry verticals in the region and developing technologies to identify the biomarkers of disease. The increasing demand for cancer treatment and the occurrence of cancer in North America is fueling the market growth, as around 1.2 million women have tested for biopsies each year in the US. And around 20% of them have been diagnosed with breast cancer. Moreover, the availability of skilled professionals and healthcare facilities with novel diagnostic techniques and medicines is stimulating the growth of the market in the forecast period.
Further, the companies like NanoString Technologies are launching new initiatives and programs for improving translational applications and this factor is likely to boost the market growth in a positive direction. NanoString Technologies have launched an initiative program called Technology Access Program (TAP) and by this program, the company will study tissue specimens of patients by using spatial molecular Imager and GEoMx Digital Spacial Profiler.
Asia Pacific accounted for a reasonable share in the Spatial OMICS market. Factors attributing to the growth of the region are increasing no. companies entering the market together with the biological activities and research studies and these factors are likely to boost the application of Spatial OMICS tools in the forecast period.
The objective of the report is to present a comprehensive analysis of the Global Spatial OMICS Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Spatial OMICS Market dynamics, structure by analyzing the market segments and project the Global Spatial OMICS Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Spatial OMICS Market make the report investor’s guide
Spatial OMICS Market Recent Industry Developments
| Date | Company | Development | Impact |
|---|---|---|---|
| 11 February 2025 | Stellaromics | Stellaromics closed an $80 million Series B financing round led by Catalyst4 and Stanford University Ventures to scale its 3D spatial biology platform, Pyxa. | The funding accelerates commercialization of thick-tissue 3D spatial transcriptomics, enabling researchers to process intact tissue samples without physical sectioning. |
| 07 August 2025 | 10x Genomics | 10x Genomics entered into a definitive agreement to acquire Scale Biosciences for $30 million in upfront cash and stock plus milestone considerations. | The acquisition integrates combinatorial indexing and quantum barcoding technologies into 10x's single-cell and spatial workflows, significantly expanding throughput scalability and experiment affordability. |
| 09 October 2025 | Bio-Techne | Bio-Techne expanded its commercial collaboration with Oxford Nanopore Technologies through 2032 to develop targeted enrichment sequencing kits for genetic screening and spatial diagnostics. | The agreement strengthens Bio-Techne's Diagnostics and Spatial Biology segment, providing simplified molecular sensing workflows for translational and clinical laboratories. |
| 03 March 2026 | MGI Tech | MGI Tech completed the acquisition of STOmics and CycloneSEQ to integrate spatial multi-omics and long-read nanopore sequencing technologies in-house. | The deal combines Stereo-seq nanoscale resolution transcriptomics with MGI's DNBSEQ platform, establishing a comprehensive end-to-end spatial-temporal omics workflow for oncology and developmental biology research. |
Global Spatial OMICS Market Scope: Inquire before buying
| Global Spatial OMICS Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 436.48 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 6% | Market Size in 2034: | US $ 737.42 Mn. |
| Segments Covered: | by Application | Academic & Translational Research Institutes Pharmaceutical and Biotechnology Companies |
|
| by Technology | Spatial Transcriptomic Spatial Genomics Spatial Proteom |
||
| by Workflow | Sample Preparation Instrumental Analysis Data Analysis |
||
| by Sample Type | FFPE Fresh Frozen |
||
Global Spatial OMICS Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Global Spatial OMICS Market, Key Players are
1. 10x Genomics
2. Dovetail Genomics
3. S2 Genomics, Inc.
4. NanoString Technologies, Inc.
5. Seven Bridges Genomics
6. PerkinElmer, Inc.
7. Bio-Techne
8. Danaher Corporation
9. IonPath, Inc.
10. Millennium Science Pty Ltd.
11. Akoya Biosciences, Inc.
12. Fluidigm Corporation
13. Diagenode Diagnostics
14. Biognosys AG
15. Rebus Biosystems
16. Ultivue, Inc.
17. Vizgen Corp.
18. BioSpyder Technologies
19. Bruker
20. Brooks Automation, Inc
Frequently Asked Questions:
1. Which region has the largest share in Global Spatial OMICS Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Spatial OMICS Market?
Ans: The Global Spatial OMICS Market is growing at a CAGR of 6% during forecasting period 2026-2034.
3. What is scope of the Global Spatial OMICS market report?
Ans: Global Spatial OMICS Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Spatial OMICS market?
Ans: The important key players in the Global Spatial OMICS Market are – 10x Genomics, Dovetail Genomics, S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, PerkinElmer, Inc., Bio-Techne, Danaher Corporation, IonPath, Inc., Millennium Science Pty Ltd., Akoya Biosciences, Inc., Fluidigm Corporation, Diagenode Diagnostics, Biognosys AG, Rebus Biosystems, Ultivue, Inc., Vizgen Corp., BioSpyder Technologies, Bruker, Brooks Automation, and Inc
5. What is the study period of this market?
Ans: The Global Spatial OMICS Market is studied from 2020 to 2034.